Boston Scientific Corporation

BSX 
(NYSE) 
 
$ 42.50 <%= Resources.Global.txtUp %>
Updated 21/07/2019
Change % 0.59% Stock price increasing
Change 0.25 Stock price increasing
Volume 1,200,324
High $ 42.75
Low $ 42.32
Open $ 42.47
ISIN
Prev close $ 42.25
# of shares 1,390.65M
Market cap 59,103M USD
Intraday

Market closed
Boston Scientific Corporation
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  42.50 1.5% Stock price increasing 1.9% Stock price increasing 18.4% Stock price increasing 14.3% Stock price increasing 26.1% Stock price increasing
Powered by TradingView

News about Boston Scientific Corporation

  • English
  • Regulatory news
24 Jun
 
21 Jun
 
21 Jun
 
20 Jun
 
20 Jun
 
17 Jun
 
17 Jun
 
15 Jun
 
14 Jun
 
12 Jun
 

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 88.07 5.9% Stock price increasing 3.6% Stock price increasing 15.7% Stock price increasing 26.0% Stock price increasing 39.4% Stock price increasing 21.8% Stock price increasing
 
Becton Dickinson and Company 252.51 0.4% Stock price increasing 2.1% Stock price increasing 10.7% Stock price increasing 5.6% Stock price increasing 2.2% Stock price increasing 12.1% Stock price increasing
 
Johnson & Johnson 128,64 -2.9% Stock price decreasing -9.5% Stock price decreasing -8.0% Stock price decreasing -0.1% Stock price decreasing 1.6% Stock price increasing -0.3% Stock price decreasing
 
Abiomed Inc 263.97 4.0% Stock price increasing 3.1% Stock price increasing 0.7% Stock price increasing -21.7% Stock price decreasing -37.7% Stock price decreasing -18.8% Stock price decreasing
 
Edwards Lifesciences Corporati.. 194.01 3.5% Stock price increasing 0.4% Stock price increasing 7.2% Stock price increasing 15.7% Stock price increasing 27.1% Stock price increasing 26.7% Stock price increasing

Company profile

Boston Scientific Corp produces less-invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract tests, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Peers

Instruments Last Change  
Abbott Labor.. 88.07 0.7% Stock price increasing
Becton Dicki.. 252.51 0.7% Stock price increasing
Johnson & Jo.. 128,64 -1.3% Stock price decreasing
Abiomed Inc 263.97 1.3% Stock price increasing
1,31,12,24,34,30,44,28,26,5
Edwards Life.. 194.01 -0.2% Stock price decreasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
23 July 2019 08:35:43
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB2 - 2019-07-23 09:35:43 - 2019-07-23 08:35:43 - 1000 - Website: OKAY